Renal and hemodynamic effects of combination therapy in hypertension.
D000328:Adult; D000368:Aged; D000618:Aminohippuric Acids / Q000378:metabolism; D001786:Blood Glucose; D001794:Blood Pressure; D001806:Blood Urea Nitrogen; D004359:Drug Therapy, Combination; D004562:Electrocardiography; D005260:Female; D005919:Glomerular Filtration Rate; D006321:Heart / Q000503:physiopathology; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D006852:Hydrochlorothiazide / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D007444:Inulin / Q000378:metabolism; D007668:Kidney / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D009929:Organ Size; D011188:Potassium / Q000378:metabolism; D012110:Reserpine / Q000627:therapeutic use; D012964:Sodium / Q000378:metabolism; D013997:Time Factors; D014527:Uric Acid / Q000097:blood; D014655:Vascular Resistance
D000618:Aminohippuric Acids; D001786:Blood Glucose; D006852:Hydrochlorothiazide; D014527:Uric Acid; D006830:Hydralazine; D012110:Reserpine; D007444:Inulin; D012964:Sodium; D011188:Potassium